These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 3499082

  • 21. Incorporation of 35sulfate into the glomerular basement membrane in puromycin aminonucleoside nephrosis.
    Garin EH, Boggs KP, Burke FC.
    Int J Pediatr Nephrol; 1985; 6(2):117-20. PubMed ID: 4030221
    [Abstract] [Full Text] [Related]

  • 22. Modulation of basement membrane component gene expression in glomeruli of aminonucleoside nephrosis.
    Nakamura T, Ebihara I, Shirato I, Tomino Y, Koide H.
    Lab Invest; 1991 May; 64(5):640-7. PubMed ID: 2030578
    [Abstract] [Full Text] [Related]

  • 23. Experimentally induced puromycine aminonucleoside nephrosis (PAN) in rats: evaluation of angiogenic protein platelet-derived endothelial cell growth factor (PD-ECGF) expression in glomeruli.
    Seckin I, Uzunalan M, Pekpak M, Kokturk S, Sonmez H, Oztürk Z, Demirci S, Yaprak E.
    J Biomed Sci; 2012 Feb 16; 19(1):24. PubMed ID: 22335899
    [Abstract] [Full Text] [Related]

  • 24. Triptolide protects podocytes from puromycin aminonucleoside induced injury in vivo and in vitro.
    Zheng CX, Chen ZH, Zeng CH, Qin WS, Li LS, Liu ZH.
    Kidney Int; 2008 Sep 16; 74(5):596-612. PubMed ID: 18509322
    [Abstract] [Full Text] [Related]

  • 25. Ameliorative effects of dietary protein restriction in chronic aminonucleoside nephrosis.
    Diamond JR, Karnovsky MJ.
    J Lab Clin Med; 1987 May 16; 109(5):538-44. PubMed ID: 3572200
    [Abstract] [Full Text] [Related]

  • 26. Amelioration of antioxidant enzyme suppression and proteinuria in cyclosporin-treated puromycin nephrosis.
    Wang JS, Yang AH, Chen SM, Young TK, Chiang H, Liu HC.
    Nephron; 1993 May 16; 65(3):418-25. PubMed ID: 8289993
    [Abstract] [Full Text] [Related]

  • 27. Severe proteinuria without impairment of sodium and volume excretion after puromycin aminonucleoside administration in rats.
    Palluk R, Veress AT, Sonnenberg H.
    Pharmacology; 1989 May 16; 38(4):214-25. PubMed ID: 2526952
    [Abstract] [Full Text] [Related]

  • 28. Altered expression of NDST-1 messenger RNA in puromycin aminonucleoside nephrosis.
    Nakayama K, Natori Y, Sato T, Kimura T, Sugiura A, Sato H, Saito T, Ito S, Natori Y.
    J Lab Clin Med; 2004 Feb 16; 143(2):106-14. PubMed ID: 14966466
    [Abstract] [Full Text] [Related]

  • 29. An ultrastructural study of the effect of the steroid in puromycin aminonucleoside nephrosis rats.
    Fujiwara Y.
    Virchows Arch A Pathol Anat Histopathol; 1984 Feb 16; 405(1):11-24. PubMed ID: 6438895
    [Abstract] [Full Text] [Related]

  • 30. Glomerular expression of smooth-muscle myosin heavy-chain isoforms in aminonucleoside nephrosis in rats.
    Nakamura T, Kimura K, Ebihara I, Takahashi T, Tomino Y, Aikawa M, Yazaki Y, Nagai R, Koide H.
    Clin Sci (Lond); 1995 Jul 16; 89(1):45-52. PubMed ID: 7671567
    [Abstract] [Full Text] [Related]

  • 31. Effect of a low-protein diet on expression of non-muscle type myosin heavy-chain isoforms in glomeruli of rats with puromycin aminonucleoside nephrosis.
    Koide H, Nakamura T, Kimura K, Ebihara I, Nagai R, Tomino Y.
    Nephrol Dial Transplant; 1996 Sep 16; 11(9):1769-74. PubMed ID: 8918620
    [Abstract] [Full Text] [Related]

  • 32. Dual effects of lisinopril on puromycin aminonucleoside nephrosis in unilaterally nephrectomized rats.
    Shinosaki T, Takagawa I, Sunagawa N, Yonetani Y, Kurihara H.
    Jpn J Pharmacol; 1997 Apr 16; 73(4):337-45. PubMed ID: 9165371
    [Abstract] [Full Text] [Related]

  • 33. Protection of alpha(3) integrin-mediated podocyte shape by superoxide dismutase in the puromycin aminonucleoside nephrosis rat.
    Kojima K, Matsui K, Nagase M.
    Am J Kidney Dis; 2000 Jun 16; 35(6):1175-85. PubMed ID: 10845833
    [Abstract] [Full Text] [Related]

  • 34. Caffeine augments proteinuria in puromycin-aminonucleoside nephrotic rats.
    Tofovic SP, Rominski BR, Bastacky S, Jackso EK, Kost CK.
    Ren Fail; 2000 Mar 16; 22(2):159-79. PubMed ID: 10803761
    [Abstract] [Full Text] [Related]

  • 35. Active vitamin D and its analogue, 22-oxacalcitriol, ameliorate puromycin aminonucleoside-induced nephrosis in rats.
    Matsui I, Hamano T, Tomida K, Inoue K, Takabatake Y, Nagasawa Y, Kawada N, Ito T, Kawachi H, Rakugi H, Imai E, Isaka Y.
    Nephrol Dial Transplant; 2009 Aug 16; 24(8):2354-61. PubMed ID: 19297354
    [Abstract] [Full Text] [Related]

  • 36. Retinoids as a potential treatment for experimental puromycin-induced nephrosis.
    Moreno-Manzano V, Mampaso F, Sepúlveda-Muñoz JC, Alique M, Chen S, Ziyadeh FN, Iglesias-de la Cruz MC, Rodríguez J, Nieto E, Orellana JM, Reyes P, Arribas I, Xu Q, Kitamura M, Lucio Cazana FJ.
    Br J Pharmacol; 2003 Jun 16; 139(4):823-31. PubMed ID: 12813006
    [Abstract] [Full Text] [Related]

  • 37. Suppression of proteinuria by dipyridamole in rats with aminonucleoside nephropathy.
    Nagase M, Kumagai H, Honda N.
    Ren Physiol; 1984 Jun 16; 7(4):218-26. PubMed ID: 6473895
    [Abstract] [Full Text] [Related]

  • 38. Suppressive effect of dipyridamole on the proteinuria of aminonucleoside nephrosis in rat.
    Kimura K, Endou H, Sakai F.
    J Toxicol Sci; 1979 Feb 16; 4(1):1-10. PubMed ID: 480401
    [Abstract] [Full Text] [Related]

  • 39. Effect of captopril on chronic puromycin aminonucleoside nephrosis in rats.
    Radin MJ, Wilke WL, Fettman MJ.
    Res Commun Chem Pathol Pharmacol; 1986 Nov 16; 54(2):279-82. PubMed ID: 3538253
    [Abstract] [Full Text] [Related]

  • 40. Inhibition of glomerular visceral epithelial cell endocytosis during nephrosis induced by puromycin aminonucleoside.
    Schwartz MM, Sharon Z, Pauli BU, Lewis EJ.
    Lab Invest; 1984 Dec 16; 51(6):690-6. PubMed ID: 6389977
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.